Browse > Article

Protective Effect of Kefir Grain Against Dextran Sodium Sulfate-Induced Colitis in Rats  

Ko, Young-Eun (Department of Food and Nutrition, Chungnam National University)
Kim, Mi-Kyoung (DMJ Biotechnology Research Institute, DMJ Biotech Corp.)
Cho, Han-Young (DMJ Biotechnology Research Institute, DMJ Biotech Corp.)
Lee, In-Young (DMJ Biotechnology Research Institute, DMJ Biotech Corp.)
Ly, Sun-Yung (Department of Food and Nutrition, Chungnam National University)
Publication Information
Journal of Nutrition and Health / v.41, no.5, 2008 , pp. 391-401 More about this Journal
Abstract
Probiotics have emerged as a potential treatment modality for numerous gastrointestinal disorders, including IBD. However, few probiotics have undergone appropriate preclinical screening in vivo. Kefir is considered a probiotic, benefiting the host through its effects in the intestinal tract. Despite numerous studies examining the action of probiotics on the host organism, few have analyzed the effects on intestinal environment. We assessed the protective effect of kefir for three weeks before inducing colitis with 2% dextran sodium sulfate for five days. The DSS loads were similar in all DSS treatment group. The results of the experiment are as follows. Food intake and FER of experimental groups were not significantly different each other, but water consumption tended to be higher in all DSS treatment groups as compared with the normal control. And visual inspection of feces revealed mild diarrhea in rat given 2% DSS. The anti-inflammatory activity of kefir was determined by myeloperoxidase activity during the DSS treatment, and there was no significant difference in any group. The levels of thiobarbituric acid reactive substances (TBARS) as a colonic lipid peroxidation were significantly lower in the kefir intake groups than in rats treated with 2% DSS alone. The DNA % in tail and tail moment values as a DNA damage level of the blood lymphocytes in kefir intake groups tended to be lower than 2% DSS treatment alone, especially tail lengths were significantly diminished. According to the colonic histopathological assay, there were a severe inflammation of lamina propria and submucosa and mild edema in mucosa and sub mucosa in DSS alone treated group. We found a slight regenerative change in kefir treatment groups. In our experiments, this means that ulcerative colitis related to oxidative injury might be prevented by kefir as a probiotic. Further studies of the potential benefits of kefir as a probiotic in inflammatory condition are encouraged.
Keywords
kefir; DSS-induced colitis; thiobarbituric acid reactive substances; DNA fragmentation;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998; 115: 182-205   DOI   ScienceOn
2 Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev 2002; 15(1): 79-94   DOI   ScienceOn
3 Weitzma SA, Gordon LI. Inflammation and cancer: role of phagocyte- generated oxidants in carcinogenesis. Blood 1990; 76: 655- 663
4 Yoshida N, Yoshikawa T, Yamaguchi T, Naito Y, Tanigawa T, Murase H, Kondo M. A novel water-soluble vitamin E derivbative protects against experimental colitis in rats. Antioxid Redox Signal 1999; 1: 555-562   DOI   ScienceOn
5 Ohshima H, Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res 1994; 305: 253-264   DOI
6 Dieleman LA, Ridwan BU, Tennyson GS, Beagley KW, Bucy RP, Elson CO. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 1994; 107(6): 1643   DOI
7 Elson CO, Sartor RB, Tennyson GS, Riddell RH. Experimental models of inflammatory bowel diesease. Gastroenterology 1995; 109: 1344   DOI   ScienceOn
8 Kitajima S, Takoma S, Morimoto M. Changes in colonic mucosal permeability mouse colitis induced with dextran sulfate sodium. Exp. Animal 1999; 48: 137-143   DOI   ScienceOn
9 Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 1976; 72: 248-254   DOI   ScienceOn
10 Burton KA. Study of conditious and mechanisms of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J 1965; 62: 315
11 Gionchetti P, Rizzello F, Helwig U, Venturi A, Lammers KM, Brigidi P, Vitali B, Poggioli G, Miglioli M, Campieri M. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 2003; 124: 1202-1209   DOI   ScienceOn
12 Ichikawa H, Huroiwa T, Inagaki A, Shineha R, Nishihira T, Satomi S, Sakata T. Probiotic bacteria stimulate gut epithelial cell proliferation in rat. Digestive Disease and Sciences 1999; 44: 2119-2123   DOI   ScienceOn
13 Yan F, Polk DB. Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. Journal of Biological Chemistry 2002; 277: 50959-50965   DOI   ScienceOn
14 Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003; 361: 512-519   DOI   ScienceOn
15 Doron S, Gorbach SL. Probiotics: their role in the treatment and prevention of disease. Expert Rev Anti Infect Ther 2006; 4(2): 261-275   DOI
16 Oz HS, McClain CJ, Nagasawa H, Mukunda R, Chen TS. Antioxidants as novel therapy in a murine model of colitis. Journal of Nutritional biochemistry 2005; 16: 297-304   DOI   ScienceOn
17 Togawa J, Nagase H, Tanaka K, Inamori M, Nakajima A, Ueno N, Saito T, Sekihara H. Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. Journal of Gastroenterology and Hepatology 2002; 17(13): 1291-1298   DOI   ScienceOn
18 Stucchi AF, Shofer S, Leeman S, Materne O, Beer E, Mcclung J, Shebini K, Moore F, O'brien M, Becker JM. NK-1 antagonist reduces colonic inflammation and oxidative stress in dextran sulfate- induced colitis in rats. Am J Physiol 2000; 279: 1298-1306
19 Girgin F, Karaoglu O, Tuzun S, Erkus M, Ozutemiz O, Dincer C, Batur Y, Tanyalcin T. Effects of trimetazindine in ethanol and acetic acid induced colitis: oxidant/anti-oxidant status. Colorectal Disease 1999; 1: 338-346   DOI
20 Tsutomu N, Junko N, Kiichirou T, Yoshinori K, Sun-yup S, Kenichi K, Sennosuke T, Koichiro T, David WB, Sanetaka S. Suppression of UVC-induced cell damage and enhancement of DNA repair by the fermented milk, Kefir. Cytotechnology 2002; 40: 125-137   DOI
21 Osman N, Adawi D, Ahrne S, Jeppsson B, Molin G. Modulation of the effect of dextran sulfate sodium-induced acute colitis by the administration of different probiotic strains of Lactobacillus and Bifidobacterium. Digestive Diseases and Sciences 2004; 49: 320-327   DOI   ScienceOn
22 Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358   DOI   ScienceOn
23 Fujiwara M, Kaneko T, Iwana H, Taketomo N, Tsunoo H, Kanno J, Ohkusa T, Okayasu I. Inhibitory effects of Bifidobacterium longum on experimental ulceratice colitis induced in mice by synthetic dextran sulfate sodium. Digestion 2003; 67: 90-95   DOI   ScienceOn
24 Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984; 87: 1344-1350
25 Boumpas DT, Chrousos GP, Wilder RL. Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med 1993; 119: 1198-1208   DOI
26 Furrie E. Probiotics and allergy. 2005; 64(4): 465-469
27 Venturi A, Gionchetti P, Rizzello F, Johansson R, Zucconi E, Brigidi P, Matteuzzi D, Campieri M. Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Alimentary Pharmacology and Therapeutics 1999; 13: 1103-1108   DOI   ScienceOn
28 Fuller R, Gibson GR. Modification of the intestinal microflora using probiotics and prebiotics. Scand J Gastroenterol 1977; 222: 28-31
29 Embvani E, Tardieu D, Jaeg JP, Corpet DE, Petit C. Dextran sulfate enhances the level of an oxidative DNA damage biomarker, 8-oxo-7,8-dihydro-2'-deoxyguanosine, in rats colonic mucosa. Toxicology Letters 1998; 95(1): 190
30 Grisham MB, Granger DN. Neutrophil-mediated mucosal injury. Role of reactive oxygen metabolites. Digestive Diseases and Sciences 1988; 33: 6S-15S   DOI
31 Williams JG, Hughes LE, Hallett MB. Toxic oxygen metabolite production by circulating phagocytic cells in inflammatory bowel disease. Gut 1990; 31(2): 187-193   DOI   ScienceOn
32 Kandler O, Kunath P. Lactobacillus kefir sp., component of microflora of kefir. Syst. Appl Microbiol 1983; 4: 286-294   DOI
33 Kopp-Hoolihan L. Prophylactic and therapeutic uses of probiotics: a review. J Am Diet Assoc 2001; 101(2): 229-238   DOI   ScienceOn
34 Kurutas EB, Cetinkaya A, Bulbuloglu E, Kantarceken B. Effects of antioxidant therapy on leukocyte myeloperoxidase and Cu/Znsuperoxide dismutase and plasma malondialdehyde levels in experimental colitis. Mediators of inlfammation 2005; 6: 390-394
35 Egger B, Bajaj-Elliott M, MacDonald TT, Inglin R, Eysselein BE, Buchler MW. Characterisation of acute murine dextran sodium sulfate colitis: cytokine proile and does dependency. Digestion 2000; 62: 240-248   DOI   ScienceOn
36 Msiewicz JJ, Lennard-hones JE, Connell AM. controlled trial of sulfasalazine in maintenance therapy for ulcerative colitis. Lancet 1965; 1: 185-188   DOI   ScienceOn
37 Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the american institute of nutrition ad hoc writing committee on the reformulation of the AIN- 76A rodent diet. J Nutr 1993; 123(11): 1939-1951   DOI
38 Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990; 98(3): 694-702   DOI
39 Kimura I, Nagahama S, Kawasaki M, Kataoka M, Sato M. Study on the experimental ulcerative colitis model induced by dextran sulfate sodium in rat. Nippon Yakurigaku Zasshi 1996; 108(5): 259-266   DOI   ScienceOn
40 Dieleman LA, Goerres MS, Arends A, Sprengers D, Torrice C, Hoentjen F, Grenther WB, Sartor RB. Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut 2003; 52: 370-6   DOI   ScienceOn
41 Mombaerts P, Mizoguchi E, Grusby MJ, Glimcher LH, Bhan AK, Tonegawa S. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 1993; 75: 274- 282
42 Bradley PR, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: Estimation of Neutrophil content with an enzyme marker. J Invest Dermatol 1982; 78(3): 206-209   DOI   ScienceOn
43 Souza MM, Aguilar-Nascimento JE, Gomes-da-Silva MH, Carlos Junior R. Effects of budesonide and probiotics enemas on the colonic mucosa of rats with experimental colitis. Acta Cir Bras 2007; 22(1): 34-38
44 Mahgoub AA, El-Medany AA, Hager HH, Mustafa AA, El- Sabah DM. Evaluating the prophylactic potential of zafirlukast against the toxic effects of acetic acid on the rat colon. Toxicol Lett 2003; 145(1): 79-87   DOI   ScienceOn
45 Mao Y, Nobaek S, Kasravi B, Adawi D, Stenram U, Morin G, Jeppsson B. The effects of Lactoba-cillus strains and Oat fiber on methotrexate-induced enterocolitis in rats. Gastroenterology 1996; 111(2): 334-344   DOI   ScienceOn
46 Mabley JG, Pacher P, Liaudet L, Soriano FG, Hasko G, Marton A, Szabo C, Salzman AL. Inosine reduces inflammation and improves survival in a murine model of colitis. Am J physiol Gastrointest Liver Physiol 2003; 284(1):138-144   DOI
47 Grip O, Janciauskiene S, Lindgren S. Macrophages in inflammatory bowel disease. Curr Drug Targets Inflamm Allergy 2003; 2: 115-160
48 Guarner F, Schaafsma GJ. Short communication Probiotics. Int. Jour of Food Microbiol 1998; 39: 237-238   DOI   ScienceOn
49 Dong Shin Kim, Sang Kyo Park, Kwak Hae Soo, Kil Wang Lee. Isolation, Identification and Characterization of Lactose Nonfermenting Yeast from Kefir Cultures. Korean J food Sci Resour 1994; 14(2): 175-178
50 Naito Y, Takagi T, Ishikawa T, Handa O, Matsumoto N, Yagi N, Matsuyama K, Yoshida N, Yoshikawa T. The inducible nitric oxide synthase inhibitor ONO-1714 blunts dextran sulfate sodium colitis in mice. European Journal of pharmacology 2001; 412: 91-99   DOI   ScienceOn
51 Giles KW, Myers A. An improved diphenylamine method for the estimation of deoxyribonucleic acid. Nature 1965; 206: 93
52 Fabia R, Willen R, Ar'Rajab A, Andersson R, Ahren B, Bengmark S. Acetic acid-induced colitis in the rat: a reproducible experimental model for acute ulcerative colitis. Eur Surg Res 1992; 24: 211-225   DOI
53 Kuhn R, Lohler J, Rennikc D, Rajewsky K, Muller W. Interleukin- 10-deficient-mice develop chronic enterocolitis. Cell 1993; 75: 263-274   DOI   ScienceOn
54 Stadnichi A, Cloman RW. Experimental models of inflammatory bowel disease. Arch Immunol Ther Exp 2003; 51(3): 149-155
55 Ohkusa T. Production of experimental ulcerative colitis in hamster by dextran sulfate sodium and changes in intestinal microflora. Jpn J Gastroenterol 1985; 82: 1327
56 Girgin F, Karaoglu O, Erkus M, Tuzun S, Ozutemiz O, Dincer C, Batur Y, Tanyalcin T. Effects of trimetazidine on oxidant/antioxidant status in trinitrobenzenesulfonic acid-induced chronic colitis. J Toxicol Environ Health A 2000; 59(8): 641-652   DOI   ScienceOn
57 Bibiloni R, Fedorak RN, Tannock GW, Madsen, KL, Gionchetti P, Campieri M, De Simone C, Sartor RB. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. American Journal of Gastroenterology 2005; 100: 1539-1546   DOI   ScienceOn
58 Lu J, Wang A, Ansari S, Hershberg RM, McKay DM. Colonic bacterial superantigens evoke an inflammatory response and exaggerate disease in mice recovering from colitis. Gastroenterology 2003; 125(6): 1785-1795   DOI   ScienceOn
59 Peran L, Camuesco D, Comalada M, Nieto A, Concha A, Adrio JL, Olivares M, Xaus J, Zarzuelo A, Galvez J. Lactobacillus fermentum, a probiotic capable to release glutathione, prevents colonic inflammation in the TNBS model of rat colitis. International Journal of Colorectal Disease 2006; 21: 737-746   DOI   ScienceOn
60 Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1983; 96(3): 795- 803
61 Guven A, Gulemez M. The effect of kefir on the activities of GSH-Px, GST, CAT, GSH and LPO levels in carbon tetrachlorideinduced mice tissues. J Vet Med 2003; 50: 412-416   DOI   ScienceOn
62 Garrote GL, Abraham AG, De Antoin GL. Inhibitory power of kefir: the role of organic acids. J. Food Prot 2000; 63: 364-369   DOI
63 Park SY, Seo DY, Suh KS, Ly SY. Oxidative stress of mouse fed with ɣ-Irradiated soybean diet. Korean J Nutr 2007; 40(2): 138- 146   과학기술학회마을
64 Liu LN, Mei QB, Liu L, Zhang F, Liu ZG, Wang ZP, Wang RT. Protective effcts of Rheum tanguticum polysaccharide against hydrogen peroxide-induced intestinal epithelial cell injury. World J Gastroenterol 2005; 11(10): 1503-1507   DOI
65 Setoyama H, Imakka A, Ishikawa H, Umesaki Y. Prevention of gut inflammation by bifidobacterium in dextran sulfate treated gnotobiotic mice associated with bacteroids strains iisolated from ulcerative colitis patients. Microbes and Infection 2003; 5: 115- 122   DOI   ScienceOn
66 Shiomi MK, Sasaki M, Murofushi K. Aibara. Antirumor activity in mice of orally administered polysaccharide from kefir grain. Jap J Medical Science and Biology 1982; 35: 75-80   DOI
67 Cuzzocrea S, Mazzon E, Serraino I, eV, nova ML, oA, Caputi. Melatonin reduces dinitrobenzene sulfonic acid-induced colitis. J Pineal Res 2001; 30(1): 1-12   DOI   ScienceOn